Search research articles
Contact Us
Filters
Showing results (41-50 of 490) with videos related to
Page
of 49
Sort By:
Journal of Clinical and Experimental Hepatology
|
September 2, 2025
Recanalizing the Path Forward: Revisiting the Role of Portal Vein Recanalization With Transjugular Intrahepatic Portosystemic Shunt in Cirrhotic Portal Vein Thrombosis
Marlene Hintersteininger, Lukas Hartl, Thomas Reiberger
Alimentary Pharmacology & Therapeutics
|
August 8, 2022
Editorial: pegylated interferon combined with bulevirtide for chronic hepatitis delta-new life for an old timer? Authors' reply
Mathias Jachs, Thomas Reiberger, Peter Ferenci
Cells
|
November 26, 2022
Treatment of Chronic Hepatitis D with Bulevirtide-A Fight against Two Foes-An Update
Peter Ferenci, Thomas Reiberger, Mathias Jachs
Journal of Hepatology
|
April 14, 2021
Reply to: "Presepsin as a biomarker of inflammation and prognosis in decompensated liver disease"
Benedikt Simbrunner, Dalila Costa, Thomas Reiberger
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
September 6, 2021
Reply
Mattias Mandorfer, Thomas Reiberger, Mathias Jachs
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
May 11, 2025
Reply
Thomas Reiberger, Nina Dominik, Michael Trauner
Alimentary Pharmacology & Therapeutics
|
December 21, 2024
Letter: Insulin-Like Growth Factor-1 in Cirrhosis Is Linked to Hepatic Dysfunction and Fibrogenesis and Predicts Liver-Related MortAlity-Authors' Reply
Lukas Hartl, Michael Schwarz, Thomas Reiberger
Alimentary Pharmacology & Therapeutics
|
January 15, 2023
Letter: chronic HDV infection-is ignorance bliss? Authors' reply
Mathias Jachs, Thomas Reiberger, Peter Ferenci
Visceral Medicine
|
October 23, 2018
Gut-Liver Axis Links Portal Hypertension to Acute-on-Chronic Liver Failure
Jonel Trebicka, Thomas Reiberger, Wim Laleman
Alimentary Pharmacology & Therapeutics
|
May 26, 2026
Editorial: Bile Acids Under Bulevirtide-A Pharmacodynamic Signature, Not a Prognostic Biomarker. Authors' Reply
Marlene Hintersteininger, Thomas Reiberger, Mathias Jachs
Page
of 49
Search research articles
Search
Showing results (41-50 of 490) with videos related to
Sort By:
Page
of 49
Journal of Clinical and Experimental Hepatology
|
September 2, 2025
Recanalizing the Path Forward: Revisiting the Role of Portal Vein Recanalization With Transjugular Intrahepatic Portosystemic Shunt in Cirrhotic Portal Vein Thrombosis
Marlene Hintersteininger, Lukas Hartl, Thomas Reiberger
Alimentary Pharmacology & Therapeutics
|
August 8, 2022
Editorial: pegylated interferon combined with bulevirtide for chronic hepatitis delta-new life for an old timer? Authors' reply
Mathias Jachs, Thomas Reiberger, Peter Ferenci
Cells
|
November 26, 2022
Treatment of Chronic Hepatitis D with Bulevirtide-A Fight against Two Foes-An Update
Peter Ferenci, Thomas Reiberger, Mathias Jachs
Journal of Hepatology
|
April 14, 2021
Reply to: "Presepsin as a biomarker of inflammation and prognosis in decompensated liver disease"
Benedikt Simbrunner, Dalila Costa, Thomas Reiberger
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
September 6, 2021
Reply
Mattias Mandorfer, Thomas Reiberger, Mathias Jachs
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
May 11, 2025
Reply
Thomas Reiberger, Nina Dominik, Michael Trauner
Alimentary Pharmacology & Therapeutics
|
December 21, 2024
Letter: Insulin-Like Growth Factor-1 in Cirrhosis Is Linked to Hepatic Dysfunction and Fibrogenesis and Predicts Liver-Related MortAlity-Authors' Reply
Lukas Hartl, Michael Schwarz, Thomas Reiberger
Alimentary Pharmacology & Therapeutics
|
January 15, 2023
Letter: chronic HDV infection-is ignorance bliss? Authors' reply
Mathias Jachs, Thomas Reiberger, Peter Ferenci
Visceral Medicine
|
October 23, 2018
Gut-Liver Axis Links Portal Hypertension to Acute-on-Chronic Liver Failure
Jonel Trebicka, Thomas Reiberger, Wim Laleman
Alimentary Pharmacology & Therapeutics
|
May 26, 2026
Editorial: Bile Acids Under Bulevirtide-A Pharmacodynamic Signature, Not a Prognostic Biomarker. Authors' Reply
Marlene Hintersteininger, Thomas Reiberger, Mathias Jachs
Page
of 49